1. Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
   G. Reid et al, 2013, Annals of Oncology CrossRef
2. Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma
   R Mezzapelle et al, 2013, British Journal of Cancer CrossRef
3. Nicotine promotes lymph node metastasis and cetuximab resistance in head and neck squamous cell carcinoma
   Rieko Shimizu et al, 2018, International Journal of Oncology CrossRef
4. New therapeutic strategies for malignant pleural mesothelioma
   Mara A. Bonelli et al, 2017, Biochemical Pharmacology CrossRef
5. Application of population physiologically based pharmacokinetic modelling to optimize target expression and clearance mechanisms of therapeutic monoclonal antibodies
   Javier Reig‐Lopez et al, 2023, British Journal of Clinical Pharmacology CrossRef
6. TGFα Promotes Chemoresistance of Malignant Pleural Mesothelioma
   Bernard Staumont et al, 2020, Cancers CrossRef
7. Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
   Federica Borea et al, 2023, International Journal of Molecular Sciences CrossRef
8. Epidermal growth factor receptor (EGFR)-targeted therapies in mesothelioma
   Puey Ling Chia et al, 2019, Expert Opinion on Drug Delivery CrossRef
9. Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival
   Puey Ling Chia et al, 2021, Lung Cancer CrossRef
10. Tumor Priming by SMO Inhibition Enhances Antibody Delivery and Efficacy in a Pancreatic Ductal Adenocarcinoma Model
    Jun Wang et al, 2019, Molecular Cancer Therapeutics CrossRef
11. Therapeutic activity of glycoengineered anti‐GM2 antibodies against malignant pleural mesothelioma
    Qi Li et al, 2015, Cancer Science CrossRef
12. Leser–Trélat syndrome in malignant mesothelioma and pulmonary adenocarcinoma: is the EGFR pathway part of the syndrome?
    Rikke Karlin Jepsen et al, 2014, Virchows Archiv CrossRef
13. Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells
    RIKI OKITA et al, 2015, Oncology Reports CrossRef
14. Current and prospective pharmacotherapies for the treatment of pleural mesothelioma
    Emyr Bakker et al, 2017, Expert Opinion on Orphan Drugs CrossRef
15. Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma
    Puey-Ling Chia et al, 2020, Pharmaceuticals CrossRef
16. Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma
    Yasuhiro Umeyama et al, 2023, Frontiers in Immunology CrossRef